Realbotix Extends Deadline for Onconetix Deal to March 31, 2027

• Realbotix extended the deadline for its subsidiary RealLLC's merger with Onconetix to March 31, 2027, from November 30, 2026.
• The transaction would list RealLLC's robotics and AI business on Nasdaq, with closing expected before the end of the first quarter of 2027.
• The parent would retain a 75-95% ownership stake and appoint four of Onconetix's five directors at closing.
• The amended agreement removes Onconetix's minimum net cash closing condition, allowing the transaction to proceed without that requirement.
• Onconetix has already advanced RealLLC $3 million toward completing the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Realbotix Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611091024BIZWIRE_USPR_____20261109_BW430619) on November 09, 2026, and is solely responsible for the information contained therein.